1 Introduction
==============

Ebola Virus (EBOV) is a virus in the family of Filoviridae and causes severe hemorrhagic fever known as Ebola Virus Disease (EVD) with a mortality rate of up to 90%. EBOV is a rather small pathogen with only seven genes. The recent outbreak with epicenter in Guinea has sparked a number of new genomics studies ([@btw610-B7]) that showed the virus proteins are not undergoing rapid evolution ([@btw610-B8]) and mutations in different EBOV proteins are correlated with lethality ([@btw610-B5]). These studies did not address highly conserved parts of proteins that we think may provide structural and functional insight into molecular functions of EBOV proteins.

There is no suitable medicine commercially available to date for EVD. Protein vaccines have failed to produce desired results in human subjects ([@btw610-B14]). Recently, host calcium channels were shown to be involved in virus host-cell entry ([@btw610-B16]) and were put forward as novel drug target. Host kinases also play a role in EVD, such as the PI3K kinase and PI3K/Akt pathways in EBOV proliferation ([@btw610-B15]). The interaction of ABL1 kinase with matrix protein VP40 has been linked to EBOV endocytosis ([@btw610-B6]). This association might facilitate morphogenesis and budding of new virions.

Different pathways and signaling cascades are routinely employed by viruses for infectivity ([@btw610-B11]). An example is the manipulation of Ras/MAPK pathways via IFN response that is associated with the elevation of EBOV infection in mice ([@btw610-B20]). The activation of Mitogen associated protein kinase (MAPK) pathways like p38 pathway including DNA damage response are dependent on ATM ([@btw610-B13]).

In order to gain more insight into the molecular biology of EVD we here aim to identify evolutionary conserved residues and assign functions to them. We do this by (i) collecting known and predicting novel post-translational modifications on EBOV proteins, (ii) mapping conserved residues on to three-dimensional structures, (iii) collect protein--protein interactions between virus and host proteins, (iv) find motifs that may mediate protein--protein interactions and (v) map conserved and modified residues to interaction interfaces.

2 Methods
=========

We calculated residue level conservation for each Ebola protein based on 520 unique EBOV genomes. We annotated these with Post-translational Modifications and motifs and mapped them to known and modeled 3D-structures. For more details see [Supplementary Methods](#sup1){ref-type="supplementary-material"}.

3 Results
=========

To identify important functions of individual residues in EBOV proteins, we combined residue conservation with several computational predictions and existing data.

3.1 Molecular functions of conserved residues
---------------------------------------------

We created multiple sequences alignments for all EBOV proteins based on whole genome sequencing data of 520 EBOV genomes and identified highly conserved regions. Next, we annotated molecular functions to those conserved regions. Post-translational modifications (PTMs) are known for their role in protein activities and it has been shown that modified residues are more conserved than unmodified residues ([@btw610-B12]). We collected published data on modified residues in Ebola proteins. Only few PTMs have been characterized so far including thirteen phosphorylation sites; thus we extended the PTM repertoire by predicting novel posttranslational modifications. As EBOV proteins reside in the human host cell, we assume human modifying enzymes can modify them. We employed widely used neural network and SVM based published prediction methods trained on human PTM data to predict modified residues on EBOV proteins. We validated this strategy against published phosphorylation data; the prediction methods were able to predict eight out of thirteen published phosphorylation sites in EBOV ([Supplementary Table S1](#sup1){ref-type="supplementary-material"}). For further analyses we included modified residues in our final repertoire that had highest prediction value and all previously published PTMs.

The new list of PTMs is composed of 10 different types and 88 conserved PTM carrying amino acid residues in seven EBOV proteins ([Fig. 1](#btw610-F1){ref-type="fig"}, [Supplementary Table S2](#sup1){ref-type="supplementary-material"}). Among predicted PTMs in EBOV proteins, phosphorylation is the most prevalent PTM type with 42 sites followed by methylation and o-glycosylation. Some of the PTMs are present in functional domains of EBOV proteins ([Supplementary Table S2](#sup1){ref-type="supplementary-material"}). Modified residues present at protein interaction interfaces may be important to virus proteins as immune escape is achieved through interaction with different host proteins ([Fig. 2](#btw610-F2){ref-type="fig"}). The presence of different PTM-types on EBOV proteins like methylation and phosphorylation in glycoprotein (GP) can explain previously missing multiplicity of EBOV protein functions and regulation. Although previously, no specific role could be found for GP lipidation ([@btw610-B9]), the conservation level suggests a crucial role, potentially in binding GP to lipid rafts together with the newly predicted conserved GPI-anchor site. The conserved SUMOylated residues in L-Protein could be responsible for nuclear localization for this protein.

![Ebola Glycoprotein (GP) conservation with post transitionally modified residues at conserved regions. PTMs present in regions of glycoprotein, conservation level indicated by dark blue, most variable residues; dark red, fully conserved sites; white, average conservation. Image created with ConSurf ([@btw610-B2]); (**A**) space filled and (**B**) backbone representation. (Abbreviation: P = phosphorylation, GPI = GPI-anchor, O = o-linked glycosylation, M = Methylation)](btw610f1){#btw610-F1}

![Ebola protein interactome. (**A**) The protein complex between VP35IID (brown) and dsRNA (green) (PDB*id*: 3L26); red residues are modified sites present in interface. (**B**) The protein complex between NP (brown)-VP35 (green) (PDB*id*: 4YPI), the PTM site present at interface shown in red. (**C**) The major interactions of EBOV proteins; left virus-virus, right host-virus. These interactions result in a number of different processes that either induce or suppress the host immune response. That is, some interactions are beneficial for the host whereas others are beneficial for the virus. The processes are grouped in boxes for each EBOV protein. Box1 shows the first step of attachment and entry of glycoprotein to host, boxes 2 and 3 are the interactive pathways to suppress the host immunity by vp35 and vp24, respectively, by interacting with host immune proteins like IRF7 (known for its role in interferon immunity); which may lead to the virus genome replication and transcription. 4, host NEDD4 play a possible role in virus budding and proliferation by interacting with and facilitating vp40 functions inside the host](btw610f2){#btw610-F2}

Interestingly, for some of the modification types no sites were predicted at all, for example we did not predict any ubiquitination site for any of EBOV proteins. The simple explanation for that may be that virus proteins may avoid degradation and thus lack sequences that resemble ubiquitination signals.

3.2 Conserved residues in 3D structures
---------------------------------------

We map conservation from multiple sequence alignments of EBOV proteins to their protein tertiary structures ([@btw610-B2]). The tertiary structures of proteins were retrieved from PDB ([@btw610-B1]). Only VP24 has a completely resolved protein structure whereas other EBOV proteins have partial structures either alone or in complex with other proteins in PDB (except for L protein). In order to evaluate the conservation of complete proteins in different structural domains, we extended our analyses to model complete EBOV proteins. We used a knowledge-based computational method to predict and refine the finished protein structures ([@btw610-B24]; [@btw610-B26]; details see [Supplementary Methods](#sup1){ref-type="supplementary-material"}). EBOV proteins contain a variety of domains of which some are completely conserved and others are completely variable ([Fig. 1](#btw610-F1){ref-type="fig"}, [Supplementary Fig. S1](#sup1){ref-type="supplementary-material"}). For example in Glycoprotein the unstructured regions have very low sequence conservation, whereas the helical parts are highly conserved. We annotate the known and predicted PTMs to conserved residues. This results in 14 modified residues present in known EBOV protein structures ([Supplementary Table S3](#sup1){ref-type="supplementary-material"}) and 88 if modeled structures are included ([Supplementary Table S2](#sup1){ref-type="supplementary-material"}).

3.3 Short motifs predict interactions with host proteins
--------------------------------------------------------

Another approach to obtain mechanistic insight into the virus protein functions is based on finding short linear motifs. We employ Gibbs sampling ([@btw610-B4]) and identify \[ST\]N.L.\[FIV\] known as Dok1 PTB domain binding motif in all EBOV proteins except for VP30 and twice in VP40. Dok proteins are adaptor molecules known for their role in regulation of signal transduction ([@btw610-B25]). Conserved PTB domains are found in many proteins and implicated for protein--protein interactions ([@btw610-B25]). Dok1 protein is known to bind through its PTB domain with protein kinases including Abelson tyrosine kinase (ABL1) ([@btw610-B3]). ATM activates ABL1 ([@btw610-B18]) and ABL1 kinase phosphorylates many targets to facilitate cellular responses like intracellular mobility and host cell exit. Recently ABL1 was shown to phosphorylate the EBOV VP40 ([@btw610-B6]) needed for the proliferation of new virus particles during the EVD. The Dok1 PTB binding motif may be crucial for this phosphorylation.

A second motif NPG.C was only found in VP30, VP35 and L protein. This motif is called phosphotyrosine independent PTB domain motif and binds Dab-like PTB domains and functionally takes part in signaling pathways like endocytosis.

3.4 Modified residues at protein interaction interfaces
-------------------------------------------------------

EBOV proteins interact with other virus proteins for spreading and with human proteins to evade host immunity or human proteins interact with EBOV proteins to accomplish immunity. To inspect the major interactions of EBOV proteins with host proteins or other virus proteins, we reconstructed the EBOV protein interactome based on literature review ([Fig. 2](#btw610-F2){ref-type="fig"}, [Supplementary Table S4](#sup1){ref-type="supplementary-material"}). We hypothesize that the residues present at the interface should be more conserved and play a functional role in protein--protein interactions. We identified conserved residues with annotated PTMs in protein interaction interfaces of known virus-host and virus-virus protein complexes from PDB ([Table 1](#btw610-T1){ref-type="table"}). Three modified sites for glycoprotein are present in the interface with neutralizing antibody, one such site in the interface between NP-VP35, one modified residue at the interface of complex with VP40-Nedd4, one modified residue between VP24 and KPNA1 and one phosphosite in the same interface motif of two different 3D structures of the VP35 inhibitory domain with dsRNA ([Supplementary Table S1](#sup1){ref-type="supplementary-material"}). The presence of these predicted modifications at conserved residues of interface of a complex between two proteins suggest an important role of PTMs in EBOV protein complex formation. Table 1Post-translational modifications in protein interactionsComplexPDB IDPTM residuesInterface residue/motifGP with antibody3VE04040GP with antibody3VE0543543GP with antibody3VE0588588VP35 with Np4PYI3030VP40 with Nedd42KQ0119119VP35 with dsRNA4LG2272271 (motif)VP35IID with dsRNA4U2X272271 (motif)VP24 with KPNA13L26138138[^1]

3.5 ATMkinase central for EBOV functions
----------------------------------------

We analyzed which kinases could be involved in the phosphorylation events of EBOV using published SVM based methods ([@btw610-B22]). We identify three potential human kinases, including ATM (ataxia telangiectasia mutated), GSK3 (glycogen synthase 3 kinase) and CK2 (casein kinase 2). The ATM kinase could be linked to the modification of the majority of phosphorylation sites ([Table 2](#btw610-T2){ref-type="table"}). The ATM kinase is a major regulator of signaling pathways like DNA damage response (DDR) pathway ([Supplementary Tables S6, S7](#sup1){ref-type="supplementary-material"}) and interacts with other important kinases and transcription factors such as ABL1, ATR, AKT1, PI3K, p53 and MDM2 ([@btw610-B10]; [@btw610-B18]; [@btw610-B19]) ([Fig. 3](#btw610-F3){ref-type="fig"}). ABL1 is a master regulator during the cytoplasmic mobility and ABL1 itself is phosphorylated by ATM kinase. Tyrosine phosphorylation of VP40 has been shown to be essential for Virion egress ([Fig. 3](#btw610-F3){ref-type="fig"}, [@btw610-B6]). The p53 and MDM2 are integral part of apoptosis, cell cycle and PI3K/Akt signaling pathways. EBOV uses PI3K signaling for cellular entry ([@btw610-B15]). Finally, ATM has been shown to regulate wnt signaling ([@btw610-B21]), both CK2 and GSK-3 are part of the wnt signaling pathway ([@btw610-B17]). Many viruses exploit DDR pathways for their own survival inside the host (reviewed elsewhere ([@btw610-B11]). Based on the presence of ATM Kinase motifs in EBOV proteins, we now suggest the activation of DDR pathways by EBOV as well ([Fig. 3](#btw610-F3){ref-type="fig"}).

![The role of ATM kinase in EVD related signaling pathways. Red arrows indicate novel interactions predicted in our analyses. Other arrows are derived from literature 1. ([@btw610-B23]) 2. ([@btw610-B13]) 3. ([@btw610-B21]) 4. ([@btw610-B6]) 5. ([@btw610-B18]) 6. ([@btw610-B19]) 7. ([@btw610-B15])](btw610f3){#btw610-F3}

Table 2Predicted host kinases and phosphorylated residues in EBOV proteinsProteinATMCK2GSK-3**Gp**59449**Vp24**177138**Vp30**182, 184, 28329**Vp35**272**Vp40**119, 195, 316**NP**193, 449, 679, 691691**L**750, 764, 913, 1036, 1264, 1303, 1993

In this study we have identified highly conserved residues in EBOV proteins and explored their functional attributes by analysis of post-translational modifications, protein--protein interactions and linear motifs. The link with ATM Kinase motifs suggests the activation of DDR pathways in the presence of EBOV may trigger the possible ATM dependent phosphorylation cascades. Together these data suggest the potential of ATM as an interesting therapeutic target to be explored in the context of EVD.
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[^1]: Modified residues overlap with residues in interaction interfaces in experimentally resolved 3D structures. Modified residue 272 of VP35 is next to the residue 271 that is part of an interaction interface.
